We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Jessica
Bennett
j.bennett24@nhs.net
Dr
Annegret
Dahlmann-Noor
Annegret.Dahlmann-Noor@nhs.net
Margaret
Wanjiru
Margaret.wanjiru1@nhs.net
Visual disturbances and blindness
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
COVID-19 has increased pressure on ophthalmology services. Paediatric amblyopia (or "lazy eye") is one condition that can benefit from a new home monitoring approach due to extensive in-clinic monitoring required in the care pathway.
Amblyopia is caused by a reduced amount of light entering the eye or lack of focus or confusion between the eyes. Suspected children are referred for orthoptic testing for diagnosis and are often given a patch to wear or drops for their better-seeing eye in order to force the affected eye to work harder. Treatment is monitored through 6-8 weekly clinic visits.
Increased frequency of visual function testing with home monitoring may increase effectiveness of treatments, reduce costs and benefit the patient.
This project aims to employ the OKKO Space Academy app as a home monitoring tool for 6 months in children aged 3-8 years with amblyopia. The smartphone app is available on iOS and Android platforms consisting of short games with applied vision science technology to measure visual function in a fun and engaging way. The concept is the child to become a space ranger in the OKKO Space Academy by completing heroic missions that centre around transporting fellow space inhabitants across the galaxy in their ship, with the help of Cosmo the Space Cat.
There are two aims of the study: 1) to determine the clinical validity of the app’s visual function measurements against the gold-standard clinic measurements and 2) to determine the feasibility of the app for patients (acceptability, usability and engagement) and clinicians (acceptability and improvement to NHS services).
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Validation of outcome measures;
You can take part if:
You may not be able to take part if:
-Parent not able to read and understand English -Patient and/or child not able to understand spoken English -Parent/child not willing to participate -Parent unable to give consent -Any other ocular comorbidities -Child has cognitive impairment or intellectual disability
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Annegret
Dahlmann-Noor
Annegret.Dahlmann-Noor@nhs.net
Margaret
Wanjiru
Margaret.wanjiru1@nhs.net
Jessica
Bennett
j.bennett24@nhs.net
The study is sponsored by MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST and funded by Innovate UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 52809
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
